These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 38966302

  • 1. Endocrine Outcomes and Associated Predictive Factors for Somatotrophin Pituitary Adenoma after Endoscopic Endonasal Transsphenoidal Surgery: 10 Years of Experience in a Single Institute.
    Geng Y, Dong Q, Cong Z, Zhu J, Li Z, Du C, Yuan F, Zeng X, Ali A, Yang J, Tang C, Ma C.
    J Neurol Surg B Skull Base; 2024 Aug; 85(4):389-396. PubMed ID: 38966302
    [Abstract] [Full Text] [Related]

  • 2. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G.
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [Abstract] [Full Text] [Related]

  • 3. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
    Hofstetter CP, Mannaa RH, Mubita L, Anand VK, Kennedy JW, Dehdashti AR, Schwartz TH.
    Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
    [Abstract] [Full Text] [Related]

  • 4. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature.
    Almeida JP, Ruiz-Treviño AS, Liang B, Omay SB, Shetty SR, Chen YN, Anand VK, Grover K, Christos P, Schwartz TH.
    J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis.
    Briceno V, Zaidi HA, Doucette JA, Onomichi KB, Alreshidi A, Mekary RA, Smith TR.
    Neurol Res; 2017 May; 39(5):387-398. PubMed ID: 28301972
    [Abstract] [Full Text] [Related]

  • 6. Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas.
    Negm HM, Al-Mahfoudh R, Pai M, Singh H, Cohen S, Dhandapani S, Anand VK, Schwartz TH.
    J Neurosurg; 2017 Aug; 127(2):397-408. PubMed ID: 27791524
    [Abstract] [Full Text] [Related]

  • 7. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
    Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ.
    Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130
    [Abstract] [Full Text] [Related]

  • 8. Endoscopic Endonasal Approach to the Growth Hormone-Secreting Pituitary Adenomas: Endocrinologic Outcome in 68 Patients.
    Taghvaei M, Sadrehosseini SM, Ardakani JB, Nakhjavani M, Zeinalizadeh M.
    World Neurosurg; 2018 Sep; 117():e259-e268. PubMed ID: 29902603
    [Abstract] [Full Text] [Related]

  • 9. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria.
    Anik I, Cabuk B, Gokbel A, Selek A, Cetinarslan B, Anik Y, Ceylan S.
    World Neurosurg; 2017 Dec; 108():278-290. PubMed ID: 28887283
    [Abstract] [Full Text] [Related]

  • 10. Endocrinological outcomes following endoscopic and microscopic transsphenoidal surgery in 113 patients with acromegaly.
    Sarkar S, Rajaratnam S, Chacko G, Chacko AG.
    Clin Neurol Neurosurg; 2014 Nov; 126():190-5. PubMed ID: 25278017
    [Abstract] [Full Text] [Related]

  • 11. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
    Taweesomboonyat C, Oearsakul T.
    World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
    [Abstract] [Full Text] [Related]

  • 12. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.
    Juraschka K, Khan OH, Godoy BL, Monsalves E, Kilian A, Krischek B, Ghare A, Vescan A, Gentili F, Zadeh G.
    J Neurosurg; 2014 Jul; 121(1):75-83. PubMed ID: 24785323
    [Abstract] [Full Text] [Related]

  • 13. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission.
    Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA.
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3190-8. PubMed ID: 23737543
    [Abstract] [Full Text] [Related]

  • 14. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly.
    Cardinal T, Collet C, Wedemeyer M, Singer PA, Weiss M, Zada G, Carmichael JD.
    Front Endocrinol (Lausanne); 2021 Aug; 12():743052. PubMed ID: 34867787
    [Abstract] [Full Text] [Related]

  • 15. Endoscopic endonasal transsphenoidal treatment for acromegaly: 2010 consensus criteria for remission and predictors of outcomes.
    Yildirim AE, Sahinoglu M, Divanlioglu D, Alagoz F, Gurcay AG, Daglioglu E, Okay HO, Belen AD.
    Turk Neurosurg; 2014 Aug; 24(6):906-12. PubMed ID: 25448208
    [Abstract] [Full Text] [Related]

  • 16. Determinants of immediate and long-term remission after initial transsphenoidal surgery for acromegaly and outcome patterns during follow-up: a longitudinal study on 659 patients.
    Guo X, Zhang R, Zhang D, Wang Z, Gao L, Yao Y, Deng K, Bao X, Feng M, Xu Z, Yang Y, Lian W, Wang R, Ma W, Xing B.
    J Neurosurg; 2022 Sep 01; 137(3):618-628. PubMed ID: 35171834
    [Abstract] [Full Text] [Related]

  • 17. The multimodal management of GH-secreting pituitary adenomas: predictive factors, strategies and outcomes.
    Buliman A, Tataranu LG, Ciubotaru V, Cazac TL, Dumitrache C.
    J Med Life; 2016 Sep 01; 9(2):187-92. PubMed ID: 27453753
    [Abstract] [Full Text] [Related]

  • 18. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
    Bourdelot A, Coste J, Hazebroucq V, Gaillard S, Cazabat L, Bertagna X, Bertherat J.
    Eur J Endocrinol; 2004 Jun 01; 150(6):763-71. PubMed ID: 15191345
    [Abstract] [Full Text] [Related]

  • 19. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients.
    Shirvani M, Motiei-Langroudi R.
    World Neurosurg; 2014 Jan 01; 81(1):125-30. PubMed ID: 23313263
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
    J Neurosurg; 2014 Dec 01; 121(6):1462-73. PubMed ID: 25237847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.